The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.35
Bid: 4.00
Ask: 4.70
Change: 0.00 (0.00%)
Spread: 0.70 (17.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.35
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

16 Mar 2018 08:03

RNS Number : 9594H
Tavistock Investments PLC
16 March 2018
 

Tavistock Investments Plc

Grant of Options 

16 March 2018

Tavistock Investments Plc ("Tavistock" or the "Company"), the financial services group, announces that it has agreed to grant two additional tranches of performance-related share options to key members of the senior management team, including Chairman, Oliver Cooke, and Chief Executive, Brian Raven.

The first tranche of the performance-related share options is over an aggregate total of 30,000,000 shares and the second tranche is over an aggregate total of 30,000,000 shares, making a combined aggregate total of 60,000,000 shares.

The exercise price of the first tranche is 6p per share, which represents a premium of 90% over the Company's current share price. The exercise price of the second tranche is 6.5p per share, which represents a premium of 106% over the Company's current share price.

Vesting of the options is conditional upon the achievement of demanding performance targets. For the first tranche of options to vest, the level of funds under management by the Group must first reach £1.8bn. For the second tranche of options to vest, the Group must report £7m of profits in a year.

The grant of options to the Directors does not form a part of their standard remuneration package and, if the options granted to them were to vest and to be exercised, the resultant shares issued to them would, in aggregate, amount to 6.5% of the current issued share capital of the Company. Accordingly, the grant is considered to be a related party transaction pursuant to Rule 13 of the AIM Rules for companies ("AIM Rules").

The number, exercise price and performance criteria of the options granted to the Directors can be summarised as follows:

Performance Hurdle

Exercise price

Number of Options

 

Brian Raven

Number of Options

 

Oliver Cooke

Tranche 1

Funds under management by Group to reach £1.8 billion

6 pence

10 million

7.5 million

Tranche 2

Group profits to reach £7 million

6.5 pence

10 million

7.5 million

 

Related Party Transaction

As the grant of options to the Directors constitutes a related party transaction under the AIM Rules, the independent directors, Roderic Rennison and Peter Dornan, have consulted with the Company's nominated adviser, Arden Partners. Having so consulted, they consider that the terms of the grant of options are fair and reasonable so far as the Company's shareholders are concerned.

Brian Raven, the Group Chief Executive, commented:

"The exercise prices and demanding performance-related vesting conditions for these options, ensure that the recipients' interests remain fully aligned with the interests of shareholders. When the performance criteria have been met, the Company's shareholders will already have benefited from substantial capital appreciation."

 

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Kitty Parry

Elspeth Rothwell

Tel: 020 3890 8118

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEGIGDXGGBBGIL
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.